<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>XLV filings -- what changed, from SEC Form N-PORT | Mulden</title><description>Each N-PORT filing of XLV compared with the one before: positions added and dropped, the largest weight changes, turnover. Computed by Mulden from the filings; dated by filing period and SEC receipt.</description><link>https://themulden.com/</link><language>en</language><item><title>XLV: filing for 2026-06-30 -- 3 added, 1 dropped, turnover 8%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>60 positions became 62: 3 added (0.47% of the fund), 1 dropped (0.32%). Turnover proxy 8%. Largest increases: Eli Lilly &amp;amp; Co 13.75% to 16.52%; UnitedHealth Group Inc 4.62% to 6.57%; CVS Health Corp 1.72% to 2.3%; AbbVie Inc 7.25% to 7.74%; Humana Inc 0.39% to 0.83%; Elevance Health Inc 1.22% to 1.46%. Largest decreases: Boston Scientific Corp 1.76% to 1.1%; Intuitive Surgical Inc 3.09% to 2.45%; Pfizer Inc 3.01% to 2.39%; Abbott Laboratories 3.37% to 2.75%; Gilead Sciences Inc 3.26% to 2.73%; Johnson &amp;amp; Johnson 11.11% to 10.64%. New: Veeva Systems Inc (0.46%), Chicago Mercantile Exchange (0.01%), CONTRA HOLOGIC INCORPO (0%). Gone: Hologic Inc (0.32%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 28 Aug 2026 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2026-03-31 -- 0 added, 2 dropped, turnover 6.3%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>62 positions became 60: 0 added (0% of the fund), 2 dropped (0.16%). Turnover proxy 6.3%. Largest increases: Johnson &amp;amp; Johnson 8.88% to 11.11%; Merck &amp;amp; Co Inc 4.65% to 5.63%; Gilead Sciences Inc 2.71% to 3.26%; Pfizer Inc 2.52% to 3.01%; Amgen Inc 3.14% to 3.57%; Bristol-Myers Squibb Co 1.96% to 2.33%. Largest decreases: Eli Lilly &amp;amp; Co 15.2% to 13.75%; Boston Scientific Corp 2.52% to 1.76%; UnitedHealth Group Inc 5.33% to 4.62%; Abbott Laboratories 3.88% to 3.37%; Intuitive Surgical Inc 3.58% to 3.09%; Thermo Fisher Scientific Inc 3.88% to 3.48%. Gone: Molina Healthcare Inc (0.16%), Chicago Mercantile Exchange (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 28 May 2026 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2025-12-31 -- 1 added, 0 dropped, turnover 5.6%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>61 positions became 62: 1 added (0% of the fund), 0 dropped (0%). Turnover proxy 5.6%. Largest increases: Eli Lilly &amp;amp; Co 11.99% to 15.2%; Merck &amp;amp; Co Inc 4.14% to 4.65%; Intuitive Surgical Inc 3.17% to 3.58%; Thermo Fisher Scientific Inc 3.62% to 3.88%; Regeneron Pharmaceuticals Inc 1.13% to 1.39%; Bristol-Myers Squibb Co 1.81% to 1.96%. Largest decreases: AbbVie Inc 8.09% to 7.19%; UnitedHealth Group Inc 6.18% to 5.33%; Abbott Laboratories 4.61% to 3.88%; Stryker Corp 2.51% to 2.15%; Pfizer Inc 2.86% to 2.52%; Boston Scientific Corp 2.86% to 2.52%. New: Chicago Mercantile Exchange (0%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 26 Feb 2026 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2025-09-30 -- 0 added, 0 dropped, turnover 4.8%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>61 positions became 61: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 4.8%. Largest increases: AbbVie Inc 6.7% to 8.09%; Johnson &amp;amp; Johnson 7.51% to 8.83%; Thermo Fisher Scientific Inc 3.13% to 3.62%; UnitedHealth Group Inc 5.78% to 6.18%; Cencora Inc 1.06% to 1.2%; IDEXX Laboratories Inc 0.88% to 1.01%. Largest decreases: Intuitive Surgical Inc 3.98% to 3.17%; Eli Lilly &amp;amp; Co 12.53% to 11.99%; Boston Scientific Corp 3.25% to 2.86%; Elevance Health Inc 1.8% to 1.44%; Vertex Pharmaceuticals Inc 2.34% to 1.99%; Cigna Group/The 1.8% to 1.52%. Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 26 Nov 2025 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2025-06-30 -- 0 added, 0 dropped, turnover 5.3%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>61 positions became 61: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 5.3%. Largest increases: Intuitive Surgical Inc 3.32% to 3.98%; Abbott Laboratories 4.33% to 4.83%; Boston Scientific Corp 2.8% to 3.25%; Stryker Corp 2.4% to 2.78%; Eli Lilly &amp;amp; Co 12.23% to 12.53%; McKesson Corp 1.59% to 1.87%. Largest decreases: UnitedHealth Group Inc 9.06% to 5.78%; Thermo Fisher Scientific Inc 3.58% to 3.13%; Bristol-Myers Squibb Co 2.33% to 1.92%; AbbVie Inc 6.95% to 6.7%; Becton Dickinson &amp;amp; Co 1.24% to 1.01%; Merck &amp;amp; Co Inc 4.27% to 4.06%. Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 28 Aug 2025 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2025-03-31 -- 0 added, 1 dropped, turnover 4.5%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>62 positions became 61: 0 added (0% of the fund), 1 dropped (0.16%). Turnover proxy 4.5%. Largest increases: AbbVie Inc 6.24% to 6.95%; Johnson &amp;amp; Johnson 6.92% to 7.51%; CVS Health Corp 1.12% to 1.61%; Abbott Laboratories 3.9% to 4.33%; Amgen Inc 2.79% to 3.15%; Gilead Sciences Inc 2.29% to 2.63%. Largest decreases: Merck &amp;amp; Co Inc 5% to 4.27%; Danaher Corp 2.93% to 2.47%; Thermo Fisher Scientific Inc 3.96% to 3.58%; Intuitive Surgical Inc 3.7% to 3.32%; Pfizer Inc 2.99% to 2.7%; Regeneron Pharmaceuticals Inc 1.49% to 1.25%. Gone: Teleflex Inc (0.16%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 28 May 2025 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2024-12-31 -- 0 added, 1 dropped, turnover 4.1%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>63 positions became 62: 0 added (0% of the fund), 1 dropped (0.19%). Turnover proxy 4.1%. Largest increases: Intuitive Surgical Inc 3.08% to 3.7%; Gilead Sciences Inc 1.85% to 2.29%; Boston Scientific Corp 2.18% to 2.62%; Bristol-Myers Squibb Co 1.86% to 2.28%; Abbott Laboratories 3.51% to 3.9%; McKesson Corp 1.13% to 1.44%. Largest decreases: Regeneron Pharmaceuticals Inc 1.97% to 1.49%; Elevance Health Inc 2.13% to 1.7%; UnitedHealth Group Inc 9.55% to 9.26%; Amgen Inc 3.06% to 2.79%; CVS Health Corp 1.4% to 1.12%; Eli Lilly &amp;amp; Co 12.36% to 12.09%. Gone: Catalent Inc (0.19%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 27 Feb 2025 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2024-09-30 -- 1 added, 2 dropped, turnover 4.3%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>64 positions became 63: 1 added (0.05% of the fund), 2 dropped (0.18%). Turnover proxy 4.3%. Largest increases: UnitedHealth Group Inc 8.72% to 9.55%; AbbVie Inc 5.63% to 6.17%; Johnson &amp;amp; Johnson 6.54% to 6.9%; Bristol-Myers Squibb Co 1.56% to 1.86%; Gilead Sciences Inc 1.59% to 1.85%; Thermo Fisher Scientific Inc 3.93% to 4.18%. Largest decreases: Eli Lilly &amp;amp; Co 13.44% to 12.36%; Merck &amp;amp; Co Inc 5.83% to 5.09%; Dexcom Inc 0.84% to 0.48%; Moderna Inc 0.74% to 0.4%; Edwards Lifesciences Corp 1.04% to 0.7%; McKesson Corp 1.41% to 1.13%. New: State Street Global Advisors (0.05%). Gone: Bio-Rad Laboratories Inc (0.1%), State Street Global Advisors (0.08%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 25 Nov 2024 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2024-06-30 -- 2 added, 3 dropped, turnover 5.2%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>65 positions became 64: 2 added (0.45% of the fund), 3 dropped (0.86%). Turnover proxy 5.2%. Largest increases: Eli Lilly &amp;amp; Co 11.33% to 13.44%; Intuitive Surgical Inc 2.57% to 2.93%; UnitedHealth Group Inc 8.36% to 8.72%; Amgen Inc 2.78% to 3.12%; Vertex Pharmaceuticals Inc 1.97% to 2.25%; Boston Scientific Corp 1.83% to 2.11%. Largest decreases: CVS Health Corp 1.83% to 1.38%; Bristol-Myers Squibb Co 2.02% to 1.56%; Johnson &amp;amp; Johnson 6.95% to 6.54%; Merck &amp;amp; Co Inc 6.11% to 5.83%; Abbott Laboratories 3.6% to 3.36%; AbbVie Inc 5.87% to 5.63%. New: Labcorp Holdings Inc (0.32%), Solventum Corp (0.14%). Gone: Illumina Inc (0.4%), Laboratory Corp of America Holdings (0.34%), DENTSPLY SIRONA Inc (0.13%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Wed, 28 Aug 2024 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2024-03-31 -- 1 added, 1 dropped, turnover 5.3%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>65 positions became 65: 1 added (0.37% of the fund), 1 dropped (0.37%). Turnover proxy 5.3%. Largest increases: Eli Lilly &amp;amp; Co 9.19% to 11.33%; Merck &amp;amp; Co Inc 5.46% to 6.11%; AbbVie Inc 5.41% to 5.87%; Intuitive Surgical Inc 2.35% to 2.57%; Stryker Corp 2% to 2.21%; Cigna Group/The 1.73% to 1.94%. Largest decreases: UnitedHealth Group Inc 9.63% to 8.36%; Johnson &amp;amp; Johnson 7.46% to 6.95%; Zoetis Inc 1.79% to 1.42%; Pfizer Inc 3.21% to 2.86%; Humana Inc 1.11% to 0.77%; Gilead Sciences Inc 2% to 1.67%. New: Cooper Cos Inc/The (0.37%). Gone: Cooper Cos Inc/The (0.37%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 28 May 2024 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2023-12-31 -- 0 added, 1 dropped, turnover 2.8%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>66 positions became 65: 0 added (0% of the fund), 1 dropped (0.09%). Turnover proxy 2.8%. Largest increases: Abbott Laboratories 3.5% to 3.78%; Eli Lilly &amp;amp; Co 8.91% to 9.19%; Intuitive Surgical Inc 2.14% to 2.35%; Vertex Pharmaceuticals Inc 1.87% to 2.08%; Dexcom Inc 0.75% to 0.95%; IDEXX Laboratories Inc 0.76% to 0.91%. Largest decreases: Pfizer Inc 3.9% to 3.21%; Bristol-Myers Squibb Co 2.52% to 2.06%; Danaher Corp 3.39% to 3.01%; Johnson &amp;amp; Johnson 7.8% to 7.46%; Becton Dickinson &amp;amp; Co 1.56% to 1.4%; Humana Inc 1.25% to 1.11%. Gone: Organon &amp;amp; Co (0.09%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 27 Feb 2024 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2023-09-30 -- 0 added, 0 dropped, turnover 4.9%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>66 positions became 66: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 4.9%. Largest increases: Eli Lilly &amp;amp; Co 7.4% to 8.91%; UnitedHealth Group Inc 8.97% to 9.72%; AbbVie Inc 4.76% to 5.47%; Amgen Inc 2.37% to 2.99%; Regeneron Pharmaceuticals Inc 1.55% to 1.83%; Danaher Corp 3.19% to 3.39%. Largest decreases: Johnson &amp;amp; Johnson 8.62% to 7.8%; Merck &amp;amp; Co Inc 5.87% to 5.44%; Abbott Laboratories 3.8% to 3.5%; Edwards Lifesciences Corp 1.15% to 0.87%; Intuitive Surgical Inc 2.4% to 2.14%; Pfizer Inc 4.15% to 3.9%. Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 27 Nov 2023 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2023-06-30 -- 0 added, 0 dropped, turnover 5%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>66 positions became 66: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 5%. Largest increases: Eli Lilly &amp;amp; Co 5.55% to 7.4%; Intuitive Surgical Inc 1.83% to 2.4%; Merck &amp;amp; Co Inc 5.53% to 5.87%; Johnson &amp;amp; Johnson 8.3% to 8.62%; Abbott Laboratories 3.62% to 3.8%; McKesson Corp 1% to 1.16%. Largest decreases: AbbVie Inc 5.78% to 4.76%; Thermo Fisher Scientific Inc 4.63% to 4.03%; Pfizer Inc 4.69% to 4.15%; Bristol-Myers Squibb Co 3.02% to 2.69%; Amgen Inc 2.65% to 2.37%; Regeneron Pharmaceuticals Inc 1.81% to 1.55%. Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 28 Aug 2023 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2023-03-31 -- 2 added, 0 dropped, turnover 4.6%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>64 positions became 66: 2 added (1.06% of the fund), 0 dropped (0%). Turnover proxy 4.6%. Largest increases: Thermo Fisher Scientific Inc 4.25% to 4.63%; Stryker Corp 1.62% to 1.97%; Regeneron Pharmaceuticals Inc 1.52% to 1.81%; Zoetis Inc 1.34% to 1.59%; Vertex Pharmaceuticals Inc 1.46% to 1.66%; Align Technology Inc 0.3% to 0.5%. Largest decreases: Pfizer Inc 5.66% to 4.69%; Johnson &amp;amp; Johnson 9.08% to 8.3%; UnitedHealth Group Inc 9.74% to 9.05%; CVS Health Corp 2.41% to 1.96%; Cigna Group/The 1.99% to 1.56%; Centene Corp 0.91% to 0.71%. New: GE HealthCare Technologies Inc (0.61%), Insulet Corp (0.45%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 30 May 2023 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2022-12-31 -- 0 added, 1 dropped, turnover 4.1%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>65 positions became 64: 0 added (0% of the fund), 1 dropped (0.25%). Turnover proxy 4.1%. Largest increases: Merck &amp;amp; Co Inc 4.79% to 5.53%; Gilead Sciences Inc 1.7% to 2.12%; AbbVie Inc 5.21% to 5.62%; Intuitive Surgical Inc 1.47% to 1.84%; Moderna Inc 0.87% to 1.17%; Pfizer Inc 5.39% to 5.66%. Largest decreases: UnitedHealth Group Inc 10.37% to 9.74%; Johnson &amp;amp; Johnson 9.43% to 9.08%; CVS Health Corp 2.75% to 2.41%; Bristol-Myers Squibb Co 3.33% to 3.01%; Medtronic PLC 2.36% to 2.03%; Danaher Corp 3.71% to 3.42%. Gone: ABIOMED Inc (0.25%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Tue, 28 Feb 2023 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2022-09-30 -- 0 added, 0 dropped, turnover 3.2%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>65 positions became 65: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 3.2%. Largest increases: UnitedHealth Group Inc 9.96% to 10.37%; Danaher Corp 3.39% to 3.71%; Eli Lilly &amp;amp; Co 5.29% to 5.6%; Regeneron Pharmaceuticals Inc 1.32% to 1.62%; CVS Health Corp 2.51% to 2.75%; Biogen Inc 0.62% to 0.85%. Largest decreases: Pfizer Inc 6.08% to 5.39%; AbbVie Inc 5.6% to 5.21%; Johnson &amp;amp; Johnson 9.66% to 9.43%; Abbott Laboratories 3.93% to 3.72%; Moderna Inc 1.02% to 0.87%; Zoetis Inc 1.67% to 1.52%. Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 28 Nov 2022 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2022-06-30 -- 0 added, 1 dropped, turnover 5.5%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>66 positions became 65: 0 added (0% of the fund), 1 dropped (0.53%). Turnover proxy 5.5%. Largest increases: Eli Lilly &amp;amp; Co 4.36% to 5.29%; Merck &amp;amp; Co Inc 3.97% to 4.77%; UnitedHealth Group Inc 9.21% to 9.96%; Johnson &amp;amp; Johnson 8.94% to 9.66%; Pfizer Inc 5.57% to 6.08%; Bristol-Myers Squibb Co 3.05% to 3.39%. Largest decreases: Intuitive Surgical Inc 2.06% to 1.49%; Illumina Inc 1.05% to 0.6%; Medtronic PLC 2.86% to 2.49%; HCA Healthcare Inc 1.15% to 0.79%; Dexcom Inc 0.95% to 0.6%; Stryker Corp 1.72% to 1.38%. Gone: Cerner Corp (0.53%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 26 Aug 2022 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2022-03-31 -- 1 added, 0 dropped, turnover 5.4%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>65 positions became 66: 1 added (0.38% of the fund), 0 dropped (0%). Turnover proxy 5.4%. Largest increases: AbbVie Inc 4.47% to 5.49%; Johnson &amp;amp; Johnson 8.4% to 8.94%; Bristol-Myers Squibb Co 2.58% to 3.05%; UnitedHealth Group Inc 8.82% to 9.21%; Merck &amp;amp; Co Inc 3.61% to 3.97%; Eli Lilly &amp;amp; Co 4.09% to 4.36%. Largest decreases: Abbott Laboratories 4.64% to 4.01%; Pfizer Inc 6.18% to 5.57%; Moderna Inc 1.67% to 1.16%; Zoetis Inc 2.15% to 1.71%; Thermo Fisher Scientific Inc 4.9% to 4.46%; Intuitive Surgical Inc 2.39% to 2.06%. New: Molina Healthcare Inc (0.38%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 27 May 2022 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2021-12-31 -- 0 added, 0 dropped, turnover 5.3%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>65 positions became 65: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 5.3%. Largest increases: UnitedHealth Group Inc 7.6% to 8.82%; Pfizer Inc 4.98% to 6.18%; AbbVie Inc 3.93% to 4.47%; Abbott Laboratories 4.32% to 4.64%; Eli Lilly &amp;amp; Co 3.79% to 4.09%; Thermo Fisher Scientific Inc 4.64% to 4.9%. Largest decreases: Moderna Inc 2.79% to 1.67%; Medtronic PLC 3.48% to 2.59%; Johnson &amp;amp; Johnson 8.77% to 8.4%; Merck &amp;amp; Co Inc 3.92% to 3.61%; Biogen Inc 0.87% to 0.66%; Stryker Corp 1.83% to 1.67%. Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 25 Feb 2022 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2021-09-30 -- 2 added, 2 dropped, turnover 5.5%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>65 positions became 65: 2 added (3.18% of the fund), 2 dropped (0.99%). Turnover proxy 5.5%. Largest increases: Thermo Fisher Scientific Inc 4.2% to 4.64%; Danaher Corp 3.61% to 3.99%; Pfizer Inc 4.64% to 4.98%; Dexcom Inc 0.87% to 1.09%; Intuitive Surgical Inc 2.31% to 2.44%; Edwards Lifesciences Corp 1.36% to 1.46%. Largest decreases: Amgen Inc 2.97% to 2.49%; Bristol-Myers Squibb Co 3.16% to 2.71%; Johnson &amp;amp; Johnson 9.19% to 8.77%; UnitedHealth Group Inc 8.01% to 7.6%; Cigna Corp 1.72% to 1.4%; AbbVie Inc 4.21% to 3.93%. New: Moderna Inc (2.79%), Bio-Techne Corp (0.39%). Gone: Alexion Pharmaceuticals Inc (0.86%), Perrigo Co PLC (0.13%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 26 Nov 2021 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2021-06-30 -- 2 added, 1 dropped, turnover 3.7%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>64 positions became 65: 2 added (0.55% of the fund), 1 dropped (0.37%). Turnover proxy 3.7%. Largest increases: Eli Lilly &amp;amp; Co 3.4% to 3.87%; Danaher Corp 3.26% to 3.61%; Intuitive Surgical Inc 1.99% to 2.31%; IDEXX Laboratories Inc 0.96% to 1.14%; Illumina Inc 1.28% to 1.46%; Edwards Lifesciences Corp 1.2% to 1.36%. Largest decreases: Johnson &amp;amp; Johnson 9.88% to 9.19%; Abbott Laboratories 4.85% to 4.36%; Amgen Inc 3.29% to 2.97%; Merck &amp;amp; Co Inc 4.46% to 4.17%; Cigna Corp 1.94% to 1.72%; Vertex Pharmaceuticals Inc 1.28% to 1.11%. New: Charles River Laboratories International Inc (0.39%), Organon &amp;amp; Co (0.16%). Gone: Varian Medical Systems Inc (0.37%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 27 Aug 2021 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2021-03-31 -- 0 added, 0 dropped, turnover 2.6%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>64 positions became 64: 0 added (0% of the fund), 0 dropped (0%). Turnover proxy 2.6%. Largest increases: Abbott Laboratories 4.55% to 4.85%; Eli Lilly and Co 3.14% to 3.4%; UnitedHealth Group Inc 7.8% to 8.04%; Cigna Corp 1.76% to 1.94%; Johnson &amp;amp; Johnson 9.71% to 9.88%; CVS Health Corp 2.1% to 2.26%. Largest decreases: Merck &amp;amp; Co Inc 4.85% to 4.46%; Intuitive Surgical Inc 2.25% to 1.99%; Thermo Fisher Scientific Inc 4.33% to 4.11%; Pfizer Inc 4.8% to 4.62%; Vertex Pharmaceuticals Inc 1.44% to 1.28%; Viatris Inc 0.53% to 0.39%. Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 28 May 2021 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2020-12-31 -- 1 added, 1 dropped, turnover 4.4%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>64 positions became 64: 1 added (0.53% of the fund), 1 dropped (0.19%). Turnover proxy 4.4%. Largest increases: AbbVie Inc 3.9% to 4.44%; UnitedHealth Group Inc 7.47% to 7.8%; Align Technology Inc 0.59% to 0.9%; Cigna Corp 1.57% to 1.76%; HCA Healthcare Inc 0.83% to 1.02%; Eli Lilly and Co 2.96% to 3.14%. Largest decreases: Amgen Inc 3.75% to 3.14%; Merck &amp;amp; Co Inc 5.29% to 4.85%; Vertex Pharmaceuticals Inc 1.79% to 1.44%; Pfizer Inc 5.14% to 4.8%; Abbott Laboratories 4.86% to 4.55%; Regeneron Pharmaceuticals Inc 1.47% to 1.19%. New: Viatris Inc (0.53%). Gone: Mylan NV (0.19%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 26 Feb 2021 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2020-09-30 -- 1 added, 0 dropped, turnover 4.6%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>63 positions became 64: 1 added (0.35% of the fund), 0 dropped (0%). Turnover proxy 4.6%. Largest increases: Thermo Fisher Scientific Inc 3.81% to 4.4%; Abbott Laboratories 4.31% to 4.86%; Danaher Corp 2.97% to 3.43%; Intuitive Surgical Inc 1.77% to 2.09%; Pfizer Inc 4.84% to 5.14%; Zoetis Inc 1.73% to 1.98%. Largest decreases: Eli Lilly and Co 3.68% to 2.96%; AbbVie Inc 4.61% to 3.9%; Gilead Sciences Inc 2.57% to 2%; CVS Health Corp 2.26% to 1.93%; Illumina Inc 1.45% to 1.14%; Cigna Corp 1.85% to 1.57%. New: Catalent Inc (0.35%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 19 Nov 2020 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2020-06-30 -- 3 added, 1 dropped, turnover 6.3%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>61 positions became 63: 3 added (1.7% of the fund), 1 dropped (1.76%). Turnover proxy 6.3%. Largest increases: AbbVie Inc 3.41% to 4.61%; Regeneron Pharmaceuticals Inc 1.18% to 1.68%; Thermo Fisher Scientific Inc 3.44% to 3.81%; UnitedHealth Group Inc 7.16% to 7.45%; Danaher Corp 2.68% to 2.97%; Illumina Inc 1.22% to 1.45%. Largest decreases: Merck &amp;amp; Co Inc 5.93% to 5.2%; Pfizer Inc 5.47% to 4.84%; Johnson &amp;amp; Johnson 10.45% to 9.87%; Biogen Inc 1.73% to 1.16%; Bristol-Myers Squibb Co 3.96% to 3.55%; Medtronic PLC 3.66% to 3.28%. New: DexCom Inc (1%), West Pharmaceutical Services Inc (0.45%), Bio-Rad Laboratories Inc (0.26%). Gone: Allergan PLC (1.76%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Thu, 27 Aug 2020 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2020-03-31 -- 0 added, 1 dropped, turnover 4.3%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>62 positions became 61: 0 added (0% of the fund), 1 dropped (0.43%). Turnover proxy 4.3%. Largest increases: Gilead Sciences Inc 2.15% to 2.86%; Eli Lilly &amp;amp; Co 2.9% to 3.55%; Johnson &amp;amp; Johnson 10.03% to 10.45%; Regeneron Pharmaceuticals Inc 0.78% to 1.18%; Vertex Pharmaceuticals Inc 1.47% to 1.85%; Centene Corp 0.68% to 1.05%. Largest decreases: State Street Global Advisors 0.7% to 0.16%; Medtronic PLC 3.97% to 3.66%; HCA Healthcare Inc 1.02% to 0.72%; Boston Scientific Corp 1.65% to 1.38%; Anthem Inc 2% to 1.74%; Pfizer Inc 5.66% to 5.47%. Gone: WellCare Health Plans Inc (0.43%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Mon, 01 Jun 2020 12:00:00 GMT</pubDate></item><item><title>XLV: filing for 2019-12-31 -- 1 added, 2 dropped, turnover 5.8%</title><link>https://themulden.com/funds/xlv/</link><guid isPermaLink="true">https://themulden.com/funds/xlv/</guid><description>63 positions became 62: 1 added (0.34% of the fund), 2 dropped (2.18%). Turnover proxy 5.8%. Largest increases: Bristol-Myers Squibb Co 2.46% to 3.93%; UnitedHealth Group Inc 6.1% to 7.28%; State Street Global Advisors 0.07% to 0.7%; Amgen Inc 3.44% to 3.74%; Cigna Corp 1.7% to 2%; Humana Inc 1.02% to 1.27%. Largest decreases: Abbott Laboratories 4.38% to 4.01%; Medtronic PLC 4.32% to 3.97%; Merck &amp;amp; Co Inc 6.38% to 6.05%; Stryker Corp 2.06% to 1.76%; Gilead Sciences Inc 2.38% to 2.15%; Pfizer Inc 5.89% to 5.66%. New: STERIS PLC (0.34%). Gone: Celgene Corp (2.08%), Nektar Therapeutics (0.09%). Weights are shares of the fund&apos;s own investments, securities-lending collateral excluded; positions matched on identifiers.</description><pubDate>Fri, 28 Feb 2020 12:00:00 GMT</pubDate></item></channel></rss>